Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Current Drugs

1989 FOUNDED
M&A STATUS
61-70 EMPLOYEES
M&A LATEST DEAL TYPE
1 FINANCING ROUNDS
Description

Provider of integrated competitor intelligence services to the research service market in London, England. The company's service provide databases, systems and services such as the Investigational Drugs database (IDdb), a resource for scientists and business executives involved in drug research and development.

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Drug Discovery
Other Industries
Other Pharmaceuticals and Biotechnology
Primary Office
  • 34-42 Cleveland Street
  • Middlesex House
  • London W1T 4LB
  • England, United Kingdom

Current Drugs Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Current Drugs‘s full profile, request access.

Request full access to PitchBook

Current Drugs Executive Team (1)

Name Title Board
Seat
Contact
Info
Ian Tarr Managing Director